University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 4P-12-3

MDSC Clinical Assay for Cancer Detection and Monitoring in Prostate Cancer.

Type: Screening
Phase: Pilot
Status: Open to Accrual
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Alan Epstein, MD,PHD
Other Trial Staff:  Charlean Ketchens, R.N., Lagrimas Ilagan, D.M., Ernesto Duverger, D.M., Yvette Viverette, R.N.

Staff may log in to see study documents.

You may participate in this study if:
1Normal men aged 25-39 with no evidence of prostate cancer and stable serum PSA.
2Normal men aged 40 and older with no evidence of prostate cancer and stable serum PSA.
3Men with elevated (>4 ng/ml) and/or rising PSA who will undergo prostate biopsy to rule out prostate cancer.
4Patients with localized prostate cancer who will undergo radical prostatectomy or radiation therapy.
5Patients with metastatic hormone-naïve prostate cancer.
6Patients with newly diagnosed castration-resistant metastatic prostate cancer.

You may not participate in this study if:
1Previous or current history of second malignancy unrelated to prostate cancer; autoimmune disease or immune deficiency, chronic treatment with immunomodulatory therapies (e.g.glucocorticoids); significant trauma, surgery, or infection in the past two weeks

For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.